Stresscopin-Related Peptide (Human)

His-Pro-Gly-Ser-Arg-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH₂
: (Hydrochloride Form)
: (M.W. 4687.5) C₂₀₅H₃₅₈N₆₈O₅₇
: Selective Ligand for Type 2 CRF Receptors

Package	Price(Yen)	Availability	Quantity
Vial 0.1 mg	18,000	Ships within 1-3 business days
バルク見積もり

Solubility: H₂O (0.1 mM)

S.Y. Hsu and A.J.W. Hsueh, Nat. Med., 7, 605 (2001). (Original)
F.M. Dautzenberg and R.L. Hauger, Trends Pharmacol. Sci., 23, 71 (2002). (Review)
V. Martínez, L. Wang, J.E. Rivier, W. Vale, and Y Taché, J. Pharmacol. Exp. Ther., 301, 611 (2002). (Pharmacol.)
A. Chanalaris, K.M. Lawrence, A. Stephanou, R.D. Knight, S.Y. Hsu, A.J.W. Hsueh, and D.S. Latchman, J. Mol. Cell. Cardiol., 35, 1295 (2003). (Pharmacol.)
C.L. Chang and S.Y.T. Hsu, Peptides, 25, 1681 (2004). (Review)
E.A. Woodcock, Endocrinology, 145, 21 (2004). (Review)
Y. Kuperman and A. Chen, Trends Endocrinol. Metab., 19, 122 (2008). (Review)
W.H. Pan and A.J. Kastin, Prog. Neurobiol., 84, 148 (2008). (Review)
P. Boonprasert, N. Lailerd, and N. Chattipakorn, Int. J. Cardiol., 127, 307 (2008). (Review)